According to literature mining, it has been found that the chemokine receptor CCR5 plays a role in determining blast malignant properties and localization of extramedullary infiltrations in acute myeloid leukemia (AML) [19]. This evidence concerns the gene CCR5 and acute myeloid leukemia.